Author Question: The nurse who is planning care for a client with GERD anticipates that the health care provider will ... (Read 84 times)

jhjkgdfhk · **on:** Jul 23, 2018

The nurse who is planning care for a client with GERD anticipates that the health care provider will order medications from which drug class?

Standard Text: Select all that apply.
1. Proton pump inhibitors
2. H2-receptor antagonists
3. Antacids
4. Diuretics
5. Antianginals

Question 2

A client is prescribed omeprazole, bismuth subsalicylate, and metronidazole for the treatment of H. pylori. The nurse explains that combination therapy will accomplish which outcome?

1. Increase the number of ulcerations
2. Eliminate the population of H. pylori
3. Allow H. pylori to adhere to the gastric mucosa
4. Immediately relieve symptoms of gastric ulceration

amcvicar · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 1,2,3
Rationale 1: Proton pump inhibitors are utilized in the treatment of GERD.
Rationale 2: H2-receptor antagonists are utilized in the treatment of GERD.
Rationale 3: Antacids are utilized in the treatment of GERD.
Rationale 4: Diuretics are not utilized in the treatment of GERD.
Rationale 5: Antianginals are not utilized in the treatment of GERD.
Global Rationale: Proton pump inhibitors, H2-receptor antagonists, and antacids are used to treat GERD. Diuretics and antianginals are not used in this therapy.

Answer to Question 2

Correct Answer: 2
Rationale 1: A goal of combination therapy is not to increase the number of ulcerations.
Rationale 2: A goal of combination therapy is to eliminate the population of H. pylori.
Rationale 3: Combination therapy will inhibit bacterial growth by disrupting their cell wall and preventing H. pylori from adhering to the gastric mucosa.
Rationale 4: The goal of combination therapy is to eradicate H. pylori and heal ulcerations. Symptoms will not immediately be relieved by this therapy.
Global Rationale: The goal of combination therapy is to eradicate H. pylori and heal ulcerations. Symptoms will not immediately be relieved by this therapy. Combination therapy will inhibit bacterial growth by disrupting their cell wall and preventing H. pylori from adhering to the gastric mucosa.